Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilgo Bruining

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Neuroscience and Biobehavioral Reviews|July 16, 2014
Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disordersKim van Elst, Hilgo Bruining, Barbara Birtoli, et al.
Plos One|February 21, 2012
Sex-dependent novelty response in neurexin-1α mutant miceMarijke C Laarakker, Niels R Reinders, Hilgo Bruining, et al.
Pediatrics|July 29, 2015
Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?Hilgo Bruining, Laurien Passtoors, Natalia Goriounova, et al.
Bioethics|May 15, 2026
Changing the Child: The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental DisordersSietske A L van Till, Maartje H N Schermer, Hilgo Bruining, et al.
Frontiers in Neurology|September 26, 2017
Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis ComplexChantal Vlaskamp, Simon-Shlomo Poil, Floor Jansen, et al.
Journal of Neurodevelopmental Disorders|October 28, 2015
Sensory modulation disorders in childhood epilepsyJolien S van Campen, Floor E Jansen, Nienke J Kleinrensink, et al.
Molecular Autism|February 13, 2014
Behavioral signatures related to genetic disorders in autismHilgo Bruining, Marinus Jc Eijkemans, Martien Jh Kas, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 21, 2024
Assessment of the excitation-inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamicsRenate Kat, Klaus Linkenkaer-Hansen, Marthe A Koopmans, et al.
Molecular Autism|May 9, 2020
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot studyDorinde M van Andel, Jan J Sprengers, Bob Oranje, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 28, 2022
Resting-state network organisation in children with traumatic brain injuryEdith Botchway, Cece C Kooper, Petra J W Pouwels, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Neuroscience and Biobehavioral Reviews|July 16, 2014
Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disordersKim van Elst, Hilgo Bruining, Barbara Birtoli, et al.
Plos One|February 21, 2012
Sex-dependent novelty response in neurexin-1α mutant miceMarijke C Laarakker, Niels R Reinders, Hilgo Bruining, et al.
Pediatrics|July 29, 2015
Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?Hilgo Bruining, Laurien Passtoors, Natalia Goriounova, et al.
Bioethics|May 15, 2026
Changing the Child: The Impact of Novel Treatments on the Identity of Children With Monogenic Neurodevelopmental DisordersSietske A L van Till, Maartje H N Schermer, Hilgo Bruining, et al.
Frontiers in Neurology|September 26, 2017
Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis ComplexChantal Vlaskamp, Simon-Shlomo Poil, Floor Jansen, et al.
Journal of Neurodevelopmental Disorders|October 28, 2015
Sensory modulation disorders in childhood epilepsyJolien S van Campen, Floor E Jansen, Nienke J Kleinrensink, et al.
Molecular Autism|February 13, 2014
Behavioral signatures related to genetic disorders in autismHilgo Bruining, Marinus Jc Eijkemans, Martien Jh Kas, et al.
Cerebral Cortex (New York, N.Y. : 1991)|May 21, 2024
Assessment of the excitation-inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamicsRenate Kat, Klaus Linkenkaer-Hansen, Marthe A Koopmans, et al.
Molecular Autism|May 9, 2020
Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot studyDorinde M van Andel, Jan J Sprengers, Bob Oranje, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 28, 2022
Resting-state network organisation in children with traumatic brain injuryEdith Botchway, Cece C Kooper, Petra J W Pouwels, et al.
Pageof 6